A target sequencing analysis did not detect any possible somatic driver mutations commonly observed in lung cancer [18], such as EGFR, HER2, KRAS, ALK, MET, or PIK3CA, suggesting that primary pulmonary malignant melanomas may have different oncogenic pathways from primary lung cancer from the viewpoint of driver oncogenes. This evidence concerns the gene PIK3CA and lung carcinoma.